News
-
Celebrating World Pharmacy Week
Tuesday | Sep 23 2025WORLD Pharmacists Day, celebrated this week on Thu 25 Sep, marks the anniversary of the inception of the International Pharmaceutical Federation (FIP) in 1912, with this year's theme being 'Think Health, Think Pharmacist'.
-
Board updates pharmacist guidance on medicinal cannabis
Tuesday | Sep 23 2025THE Pharmacy Board of Australia has today published guidance reminding pharmacists of their duty of care when supplying prescribed medicinal cannabis products, updating guidance issued earlier this year (PD 09 Jul).
-
Dispensary Corner 23 Sep 25
Tuesday | Sep 23 2025US President Donald Trump took to the White House podium this morning to offer his admittedly non-expert medical advice to the American public.
-
APC supports endorsement
Monday | Sep 22 2025THE Australian Pharmacy Council (APC) has welcomed the Pharmacy Board's announcement to establish an endorsement for scheduled medicines that will standardise the qualifications required by pharmacists who prescribe (PD 18 Sep).
-
GLP1-RAs, Keytruda on WHO essential meds list
Monday | Sep 22 2025THE World Health Organization's (WHO) Essential Medicines Lists (EMLs) have been updated for 2025, with 20 new drugs added to the adult list, including type 2 diabetes treatments popularly used for weight loss, as well as cancer drugs and rapid-acting synthetic insulin.
-
Retinoid action
Monday | Sep 22 2025DIFFERIN Acne Treatment contains the potent retinoid Adapalene to treat and prevent acne, and restore the skin's natural texture and tone.
-
All treat, no tricks
Monday | Sep 22 2025CUSTOMERS have a chance to win the ultimate Halloween treat haul - a year's supply of Glucojel products.
-
Dispensed pinged for unlawful ads
Monday | Sep 22 2025THE Therapeutic Goods Administration (TGA) has issued six infringement notices totalling $118,800, to Dispensed Pty Ltd for the alleged unlawful advertising of medicinal cannabis.
-
B3 skin cancer role
Monday | Sep 22 2025NICOTINAMIDE, a form of vitamin B3 also known as niacinamide, may help prevent skin cancer, according to US research into the over-the-counter supplement.
-
Mounjaro safe, effective for T2D kids
Monday | Sep 22 2025MOUNJARO (tirzepatide), a GIP/GLP-1 dual receptor agonist, improved blood glucose and body mass index in children and adolescents aged 10-18 with type 2 diabetes, according to trial results released by Eli Lilly last week.
